Original air date: 5.4.22
This course has expired and is no-longer eligible for CLE.
Antibodies are one of the main workhorses of biotechnology. They can be used diagnostically, therapeutically, and analytically. However, despite their widespread use, they are one of the most difficult of all inventions to effectively patent. The interplay of the written description and enablement requirements, combined with the unpredictability of this art, tends to restrict inventors to narrow claims. This webinar will discuss the obstacles to broadly claiming antibodies, ways to avoid such obstacles, international claiming strategies, data collection concerns, and the roll of prior art searches in patenting antibodies.
This webinar will address the following questions:This course has expired and is no-longer eligible for CLE.
Antibodies are one of the main workhorses of biotechnology. They can be used diagnostically, therapeutically, and analytically. However, despite their widespread use, they are one of the most difficult of all inventions to effectively patent. The interplay of the written description and enablement requirements, combined with the unpredictability of this art, tends to restrict inventors to narrow claims. This webinar will discuss the obstacles to broadly claiming antibodies, ways to avoid such obstacles, international claiming strategies, data collection concerns, and the roll of prior art searches in patenting antibodies.
- How to obtain to broadest and strongest possible patent protection (in the US and abroad)?
- How to successfully navigate the antibody patentability minefield?
- How much data is enough? When to send the inventors back to the lab.
- What does a good prior art search look like?
AIPLA is an approved provider by most jurisdictions requiring CLE. Each program requires individual jurisdiction approval, and each jurisdiction has different approval guidelines and time frames so programs may not be pre-approved for CLE. Program accreditation is sought in all attendee requested jurisdictions and may be available for up to one year after the original air date. Specialized credits (Ethics, Elimination of Bias, Diversity, Equity & Inclusion, Technology, etc.) approval varies by jurisdiction. CLE reporting and/or certificates of attendance may take up to 4 weeks for processing.
For information on CLE accreditation and processing, please contact the AIPLA CLE Department at cle@aipla.org.